effectiveness of transcranial direct current stimulation and varenicline on, excutive function, cravings and,depression, anxiety and stress in smokers with major depressive disorder
- Conditions
- People with smoking.Z72.0Tobacco use
- Registration Number
- IRCT20221214056816N1
- Lead Sponsor
- Zanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Having the ability to give informed consent to participate in research
Being at least 18 and at most 65 years old
Daily consumption of more than ten cigarettes for at least two years(14)
Non-use of other substances such as: methamphetamine, opioid and benzodiazepine (specified through clinical interview by Ballinger)
Having a diagnosis of major depression
Failure to consider other severe psychiatric disorders that will be screened through the structured interview of SKID
Consuming more than one marijuana cigarette per week
Having a history of neurological diseases such as Parkinson's, epilepsy, convulsions, strokes and cardiovascular problems
Having diseases related to the scalp
Having a history of head trauma
Presence of a device or tool in the head
Exiting from the research after absence In two continuous sessions of treatment
Pregnancy or breastfeeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decreasing score in depression, anxiety, stress Scale(DASS). Timepoint: 3 Month. Method of measurement: Dass questionnaire.;Decreasing score in mood profile. Timepoint: 3 Month. Method of measurement: mood profile questionnaire.;Decreasing score in craving questionnaire. Timepoint: 3 Month. Method of measurement: craving questionnaire.;Improving inhibition in Stroop test. Timepoint: 3 Month. Method of measurement: Stroop software.
- Secondary Outcome Measures
Name Time Method